The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).
9don MSN
Fraser Wood, 7, was diagnosed with a type of blood cancer known as lymphoblastic lymphoma after becoming ill over the summer ...
Hosted on MSN5d
Bainbridge community holds fundraisers to support 12-year-old Dahani Hicks and his battle with cancerThere is a GoFundMe and T-shirt drive set up to help support the Hicks family on this journey. All proceeds will go towards ...
Despite research showing the benefits of circulating tumor DNA as an indicator of disease remission in B-cell lymphoma, ...
Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...
With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in ...
Every year, the Leukemia & Lymphoma Society (LLS) organizes various fundraisers to support its mission and raise awareness ...
The Scottish Medicines Consortium has backed NHS funding for Gilead’s CAR-T therapy Yescarta for B-cell lymphomas ... cleared for use in acute lymphoblastic lymphoma (ALL).
SAN DIEGO — A bicistronic chimeric antigen receptor T-cell therapy induced durable response for most children with relapsed or refractory B-lineage acute lymphoblastic leukemia, findings ...
15 Lymphoma cells from a pleural effusion in a pediatric patient with T-cell lymphoblastic disease at ... Markers associated to B (CD19), NK (CD16/56) or myelomonocytic (CD13, CD33 and CD63 ...
Pet owners can bring in their cats and dogs Saturday to Wizard of Paws for nail trims that will benefit a local girl battling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback